A carregar...
Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti–Interferon-γ Autoantibodies
Patients with autoantibodies to interferon-γ (IFN-γ) may develop severe nontuberculous mycobacterial infections. We describe the novel use of daratumumab in a patient with autoantibodies to IFN-γ who had progressive infection, resulting in clinical and radiographic improvement.
Na minha lista:
| Publicado no: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8204786/ https://ncbi.nlm.nih.gov/pubmed/32745179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa1086 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|